Review of quorum quenching and other novel strategies for biofilm-associated infections in nosocomial settings

This narrative review focuses on novel therapeutic strategies for biofilm-associated infections occurring in nosocomial settings. The scope encompasses a broad range of interventions, including quorum quenching agents, enzymatic matrix disruptions, antimicrobial peptides, nanoparticles, metal complex-based interventions, and computational approaches. The authors discuss these mechanisms as potential solutions to the challenge of biofilm resistance in hospital environments.

The review does not provide specific efficacy data, sample sizes, or comparative outcomes. Key details regarding the population, primary outcomes, and follow-up duration were not reported in the source document. Consequently, no specific numerical results or p-values are available to support clinical decision-making at this stage.

Safety data, including adverse events, serious adverse events, and tolerability, were not reported. The authors do not establish causality for the proposed interventions, and the practice relevance of these findings remains unclear. Limitations acknowledged by the authors or in the text were not reported, and funding or conflict of interest information was not provided.

Clinicians should interpret these findings as a conceptual overview rather than evidence for immediate implementation. The review suggests these modalities warrant further investigation but does not currently support changing standard care based on the available synthesized information.